Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 1/1997

01-04-1997 | ORIGINAL ARTICLE

An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel

Authors: Xichen Zhang, Helen M. Burt, Daniel Von Hoff, Daniel Dexter, Gina Mangold, Donna Degen, Ann Marie Oktaba, W. L. Hunter

Published in: Cancer Chemotherapy and Pharmacology | Issue 1/1997

Login to get access
Metadata
Title
An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel
Authors
Xichen Zhang
Helen M. Burt
Daniel Von Hoff
Daniel Dexter
Gina Mangold
Donna Degen
Ann Marie Oktaba
W. L. Hunter
Publication date
01-04-1997
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 1/1997
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s002800050630

Other articles of this Issue 1/1997

Cancer Chemotherapy and Pharmacology 1/1997 Go to the issue

ORIGINAL ARTICLE

Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study

ORIGINAL ARTICLE

Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo

ORIGINAL ARTICLE

Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer

ORIGINAL ARTICLE

Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants

ORIGINAL ARTICLE

Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines

ORIGINAL ARTICLE

Combination chemotherapy involving orally administered etoposide and JM-216 in murine tumor models
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits